Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genesis Biomedical is a regenerative medicine company that develops and distributes advanced biologic products derived from human placental tissue. The company's core offerings include amniotic fluid and tissue grafts, such as Genesis Amniotic Fluid and Genesis Membrane, which are designed for use in orthopedics, wound care, and pain management. These products aim to provide non-surgical solutions for tissue repair, inflammation reduction, and accelerated healing in sports medicine and podiatry. Genesis Biomedical focuses on the clinical application of amniotic-derived growth factors and cytokines to treat chronic injuries and non-healing wounds. The company is headquartered in Hermosa Beach, California, and serves a broad network of healthcare providers across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genesis Biomedical.